Exoskeleton Market Size, Share & Growth Trend Analysis Report (2026 - 2035)

Market Outlook

The global exoskeleton market, valued at USD 2.9 billion in 2025, is projected to reach USD 3.7 billion in 2026 and USD 20.3 billion by 2035, representing a CAGR of 20.8% during the forecast period 2026 to 2035.

To learn more about this report, request a free sample copy

Market Report: Key Takeaways

Market Size & Trends

• In terms of body part covered, lower body subsegment holds the highest share, ~45% of the current market.
• Based on the mode of operation, powered mode accounts for the largest share of the current market.
• With respect to form of exoskeleton, rigid exoskeleton captures the largest share of the current market.
• By mobility, mobile exoskeletons account for the majority of the current market share.
• Based on end user, healthcare providers subsegment dominates the market.
• In terms of key geographical regions, North America currently holds the highest market share, accounting for ~45% of the overall market.

Key Market Statistics

• Market Size in 2026: USD 3.7 Billion
• Estimated Market Size in 2035: USD 20.3 Billion
• CAGR (2026-2035): 20.8%
• North America: Largest market in 2026
• Asia-Pacific: Fastest growing region

Market Introduction

The exoskeleton market is gaining relevance as mobility impairment becomes a larger clinical, social, and economic burden. Neurological conditions are now among the leading causes of disability worldwide; in 2025, the World Health Organization reported that neurological conditions affect more than 40% of the global population, representing over 3 billion people, and are responsible for more than 11 million deaths each year. This growing burden is increasing the need for rehabilitation and mobility solutions that go beyond passive support. While wheelchairs, walkers, and crutches remain important, they primarily help patients compensate for lost mobility rather than actively support functional recovery.

Exoskeletons are emerging as an important next-generation solution because they combine mobility assistance with rehabilitation-led movement training. These wearable robotic systems use sensors, motors, actuators, control software, and power units to support standing, walking, balance, and limb movement in patients with stroke, spinal cord injury, multiple sclerosis, acquired brain injury, and other neuromotor impairments. Current commercial adoption is also becoming more visible. Notably, Ekso Bionics states that its technology is used in more than 500 rehabilitation centers worldwide, while its EksoNR system is FDA-cleared for brain injury and multiple sclerosis and is the first exoskeleton cleared for both stroke and spinal cord injury.

A major recent development strengthening market access was the establishment of a Medicare reimbursement pathway for personal exoskeletons in the US. In March 2026, Lifeward reported that Aetna, Humana, and UnitedHealthcare had added Medicare Advantage coverage for the ReWalk Personal Exoskeleton, extending potential access to approximately 16 million covered individuals in the US. The company also reported that in the Q4 FY 2025 revenue from ReWalk Personal exoskeleton sales increased by 20% year-on-year, primarily due to higher reimbursed unit sales. This expansion of payer coverage is important for the market because it reduces reimbursement uncertainty, improves affordability for eligible individuals with spinal cord injuries and supports the transition of exoskeleton technology from primarily institutional rehabilitation settings toward wider personal, home, and community use.

Beyond healthcare, exoskeletons are also gaining traction in industrial and workforce-support applications, expanding the market opportunity. In April 2025, German Bionic also announced a partnership with KULR to expand AI-powered exoskeletons for the US workforce, with KULR receiving North American marketing and distribution rights. These developments indicate that exoskeletons are evolving from niche rehabilitation devices into broader wearable robotics platforms that support mobility, worker safety, rehabilitation efficiency, and long-term independence.

Medical Exoskeletons and Regulatory Milestones

Abbreviation: YoE: Year of Establishment

Market Segmentation

Based on the research, we have segmented the exoskeleton market into body part covered, mode of operation, form of exoskeleton, mobility, end user and key geographical regions.

By Body Part Covered

• Upper Body
• Lower Body
• Full Body

By Mode of Operation

• Powered
• Passive
• Hybrid

By Form of Exoskeleton

• Rigid
• Soft

By Mobility

• Fixed / Supported
• Mobile

By End User

• Patients
• Healthcare Providers
• Industry Workers
• Military Personnel
• Others

By Key Geographical Regions

• North America
• Europe
• Asia-Pacific
• Rest of the World

Exoskeleton Market Key Insights

What are the Key Drivers of Growth in the Exoskeleton Market?

• Shift from Passive Mobility Support to Active Functional Recovery: Wheelchairs, walkers, and crutches support mobility but do not actively retrain movement patterns. Exoskeletons offer a more active rehabilitation approach by assisting standing, walking, balance, and repetitive limb movement. This makes them attractive for hospitals and rehabilitation centers seeking technologies that can improve therapy intensity, support neuroplasticity, and help patients participate more actively in recovery programs.
• Technological Advancements in Sensors, AI, Control Systems, and Lightweight Materials: The market is benefiting from advances in motion sensors, AI-enabled control software, battery systems, actuators, lightweight materials, and ergonomic design. These improvements are making exoskeletons more responsive, safer, easier to use, and more suitable for clinical, homecare, and industrial environments. Recent research is also moving toward data-driven adaptive assistance for post-stroke gait, where wearable systems can adjust support based on real-time movement data and patient variability.

What are the Main Challenges to Market Growth?

• Patient Eligibility and Limited Universal Applicability: Not every patient with mobility impairment can use an exoskeleton. Suitability may depend on height, weight, bone density, cardiovascular health, balance, upper-body strength, spasticity, cognition, skin condition, and level of injury. This narrows the addressable patient base and creates a challenge for manufacturers trying to scale adoption. For example, personal exoskeletons for spinal cord injury patients may not be suitable for all users with severe paralysis or complex comorbidities.
• Limited and Uneven Reimbursement Coverage: Reimbursement remains one of the most important barriers for adoption of medical exoskeletons. Although the US has made progress by classifying certain powered exoskeletons as braces under Medicare, coverage still depends on eligibility, documentation, prior authorization, payer policies, and clinical justification. In many countries, reimbursement pathways are still unclear or limited, which restricts broader use beyond selected rehabilitation centers and privately funded patients.

Recent Developments in Exoskeleton Market

• In July 2026, Verve Motion announced strategic partnerships and investments from HexArmor/uvex and International Airlines Group to scale its SafeLift powered exosuit. HexArmor will support global commercialization, while IAG will evaluate aviation use cases across baggage handling and ground operations.
• In May 2026, Hypershell unveiled its new X Series AI-powered exoskeleton lineup, including X Ultra S, X Max S and X Pro S. The launch added HyperIntuition motion control and a HyperLIFT field-testing program for search-and-rescue applications.
• In April 2026, SUITX by Ottobock detailed its smart exoskeleton and digital ergonomics roadmap, including the Volton XP Companion app for IX BACK VOLTON and further development of IX SHOULDER AIR. The offering adds sensor-based usage analytics for industrial and logistics ergonomics programs.

Industry Experts on the Exoskeleton Market

Technological advances, including lighter, more ergonomic actuation, compact sensorized joints, wireless telemetry to eliminate tethering, higher-frequency control loops for fast transient responses, and on-device analytics for real–time diagnostics and predictive maintenance, are aligning exoskeletons with the functional, safety, and usability demands of modern medical and industrial applications.

Emphasizing this shift, Gregory Galarneau (Founder, The Exoskeleton Store), stated, "Currently, the domain serves more than 250 customers. Smaller, family-run businesses with 50 employees or fewer represent a particularly promising market, as their owners and managers are more aware of workers' daily fatigue and physical pain, have simpler approval processes, and are often more willing to adopt solutions that improve employee well-being."

Discussions with multiple stakeholders in this domain have influenced the opinions and insights presented in this study. The market report includes transcripts of the following discussions:

• Co-Founder and Chief Executive Officer, Small Company, Spain
• Director of Business Planning and Development, Small Company, Japan
• Vice President of Sales and Marketing, Small Company, US
• Founder and Director, Small Company, US
• Marketing and Design Manager, Small Company, US

In addition, the market report includes transcripts of the following other third-party discussions:

• Founder and Chief Executive Officer, Small Company, US
• Founder and Chief Executive Officer, Small Company, China
• Founder and Chief Executive Officer, Small Company, Switzerland
• Founder, Small Company, US
• Co-founder & Chief Scientific Officer, Small Company, US
• Division Head, Small Company, UK
• Scientific Chair, Technology and Innovation, Large Company, US
• Professor, Large Company, US
• Associate Professor, Large Company, US
• Wearable Robotics Researcher / Engineer, Mid-sized Company, US

Market Share Insights

Which Body Part Accounts for the Largest Share of the Overall Market?

Based on the body part covered, the global exoskeleton market is segmented into upper body, lower body and full body.

Currently, lower body subsegment holds the largest share of the exoskeleton market owing to its widespread adoption in rehabilitation, mobility assistance, and industrial applications. Majority of the commercially available exoskeleton systems are designed to restore or augment lower-limb function in individuals with spinal cord injuries, stroke, multiple sclerosis, and other neurological or musculoskeletal disorders, creating a well-established clinical demand. For example, Ekso Bionics, ReWalk Robotics, and CYBERDYNE have commercialized lower-limb exoskeletons that are widely used in rehabilitation and mobility assistance.

The upper body exoskeleton segment is expected to grow at a significant pace during the forecast period owing to its increasing adoption across industrial, manufacturing, logistics, construction, and healthcare settings to reduce upper-limb fatigue and work-related musculoskeletal disorders. Rising awareness of occupational ergonomics and workplace safety is encouraging employers to deploy wearable assistive devices that support repetitive overhead tasks and manual material handling, thereby improving worker productivity and reducing injury-related costs. Furthermore, technological advancements in lightweight materials, wearable sensors, AI-assisted motion control, and ergonomic designs are enhancing the usability and comfort of upper body exoskeletons.

Which Mode of Operation Accounts for the Largest Share of the Exoskeleton Market?

Based on the mode of operation, the global exoskeleton market is segmented into powered, passive and hybrid.

Currently, powered exoskeletons hold the largest share of the exoskeleton market owing to their superior functional capabilities and broader adoption across healthcare, industrial, and defense applications. Unlike passive systems, powered exoskeletons actively assist movement using electric motors, actuators, or hydraulic systems, making them the preferred choice for patients with severe mobility impairments, including spinal cord injuries, stroke, and neuromuscular disorders. The higher clinical effectiveness of powered systems has led to greater commercialization, regulatory approvals, and reimbursement support, particularly in rehabilitation settings. In addition, industrial employers are increasingly investing in powered exoskeletons to reduce worker fatigue and improve productivity in physically demanding tasks.

The hybrid mode segment is expected to grow at a significant pace during the forecast period owing to the increasing demand for exoskeletons that combine the mobility assistance of powered systems with the lightweight design and energy efficiency of passive technologies. Manufacturers are focusing on hybrid architectures that provide powered assistance only when needed, thereby reducing battery consumption while improving user comfort and extending operating time. This makes hybrid exoskeletons particularly attractive for long-duration industrial work, military operations, and rehabilitation programs where continuous powered assistance is unnecessary.

For example, companies such as Ottobock and German Bionic are incorporating intelligent sensing, adaptive control algorithms, and ergonomic designs to optimize assistance based on user movement and workload. Additionally, increasing investment in AI-integrated wearable robotics, rising demand for versatile exoskeletons across multiple end-use sectors, and ongoing product innovation are expected to accelerate the adoption of hybrid systems, supporting strong market growth during the forecast period.

Which Form of Exoskeleton Leads the Exoskeleton Market?

Based on the form of exoskeleton, the exoskeleton market is segmented into rigid and soft exoskeletons.

Rigid exoskeletons hold the largest share of the exoskeleton market owing to their established use in medical rehabilitation, mobility assistance, and industrial load-bearing applications that require high structural support and precise motion control. These systems provide greater stability, weight-bearing capacity, and joint alignment, making them the preferred choice for patients with spinal cord injuries, stroke, and lower-limb paralysis, where substantial mechanical assistance is required. Moreover, most commercially approved powered exoskeletons currently available are rigid in design, resulting in higher market penetration across hospitals, rehabilitation centers, and industrial workplaces.

The soft exoskeleton segment is expected to grow at a significant pace during the forecast period owing to increasing demand for lightweight, flexible, and ergonomically designed wearable assistive devices that enhance user comfort without restricting natural movement. Unlike rigid systems, soft exoskeletons are easier to wear for extended periods, making them particularly attractive for industrial workers, military personnel, elderly individuals, and patients requiring long-term mobility assistance. Furthermore, advances in smart textiles, soft robotics, wearable sensors, artificial intelligence, and lightweight actuation technologies are improving the performance and commercial viability of soft exoskeletons.

For example, SUITX (now part of Ottobock) and HeroWear have developed lightweight wearable systems for occupational ergonomics, while research institutions continue to expand clinical applications for rehabilitation. In addition, the growing emphasis on workplace injury prevention, home-based rehabilitation, and wearable assistive technologies is expected to accelerate the adoption of soft exoskeletons, supporting robust market growth during the forecast period.

In Terms of Mobility, Mobile Exoskeletons Account for the Largest Share

Based on mobility, the global exoskeleton market is segmented into fixed / supported and mobile.

Currently, mobile exoskeletons hold the largest share of the exoskeleton market owing to their broad applicability across rehabilitation, mobility assistance, industrial ergonomics, and defense sectors. Unlike stationary systems that are confined to clinical or laboratory environments, mobile exoskeletons enable users to perform daily activities and rehabilitation exercises in real-world settings, significantly expanding their commercial adoption. The increasing demand for wearable mobility solutions among patients with spinal cord injuries, stroke, and age-related mobility impairments, coupled with growing deployment in industrial workplaces to reduce worker fatigue and musculoskeletal injuries, has strengthened demand for mobile systems.

The mobile exoskeleton segment is expected to grow at a significant pace during the forecast period owing to continuous technological advancements that improve portability, battery life, artificial intelligence-based gait assistance, and user comfort. Manufacturers are increasingly developing lightweight, autonomous wearable systems that support long-duration use in home rehabilitation, industrial operations, and military applications, thereby expanding the addressable market beyond hospitals and rehabilitation centers.

For instance, Wandercraft has expanded its portfolio with personal exoskeleton solutions designed for everyday mobility, while German Bionic continues to advance AI-enabled mobile exoskeletons for industrial workers. Furthermore, increasing investment in wearable robotics, favorable reimbursement policies in selected markets, and expanding clinical evidence supporting long-term exoskeleton-assisted rehabilitation are expected to accelerate the adoption of mobile exoskeletons during the forecast period.

Regional Analysis: Which Regions are Showing the Fastest Growth in Exoskeleton Market?

In terms of key geographical regions, the global exoskeleton market is segmented into North America, Europe, Asia-Pacific and Rest of the World.

North America: Largest Regional Market

Currently, North America holds the largest share (~45%) of the exoskeleton market owing to the region's strong commercialization ecosystem, favorable reimbursement landscape for medical exoskeletons, and substantial investments in wearable robotics across healthcare, industrial, and defense sectors. Notably, the United States has been an early adopter of robotic rehabilitation technologies, supported by increasing reimbursement for exoskeleton-assisted gait training from private insurers and the US Department of Veterans Affairs, which has expanded access to exoskeletons for veterans with spinal cord injuries.

In addition, the US Food and Drug Administration has granted multiple clearances for robotic exoskeletons, facilitating their clinical adoption in rehabilitation centers and hospitals. The presence of leading manufacturers, including Ekso Bionics, ReWalk Robotics, Sarcos Technology and Robotics Corporation, and SuitX (now part of Ottobock), has further accelerated product innovation and commercialization.

Asia-Pacific: Fastest-Growing Region

The Asia-Pacific exoskeleton market is expected to grow at a significant pace during the forecast period owing to rapid industrial automation, an aging population, rising incidence of neurological disorders, and increasing government support for robotics and rehabilitation technologies. Countries such as Japan, China, and South Korea are actively promoting the development and adoption of assistive robotics through national robotics strategies and healthcare innovation programs.

For instance, Japan's Robot Care Equipment Development and Introduction Project, supported by the Ministry of Economy, Trade and Industry (METI) and the New Energy and Industrial Technology Development Organization (NEDO), has accelerated the commercialization of rehabilitation and nursing-care exoskeletons. Similarly, China's 14th Five-Year Plan for Robot Industry Development (2021-2025) identifies rehabilitation and medical robotics as strategic growth areas, encouraging domestic innovation and manufacturing.

Scope of Exoskeleton Market Report